Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Endoscopic thoracic sympathectomy for treatment of essential hyperhidrosissyndrome: Experience with 650 patients
Autore:
Reisfeld, R; Nguyen, R; Pnini, A;
Indirizzi:
Beverly Hills Ctr Special Surg, Ctr Hyperhidrosis, Los Angeles, CA 90035 USA Beverly Hills Ctr Special Surg Los Angeles CA USA 90035 les, CA 90035 USA
Titolo Testata:
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES
fascicolo: 1, volume: 10, anno: 2000,
pagine: 5 - 10
SICI:
1051-7200(200002)10:1<5:ETSFTO>2.0.ZU;2-0
Fonte:
ISI
Lingua:
ENG
Soggetto:
PALMAR HYPERHIDROSIS; THORACOSCOPIC SYMPATHICOLYSIS; TRANSTHORACIC SYMPATHECTOMY; BOTULINUM TOXIN;
Keywords:
compensatory sweating; endoscopic sympathectomy; hyperhidrosis; palmar hyperhidrosis; sympathetic chain;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
25
Recensione:
Indirizzi per estratti:
Indirizzo: Reisfeld, R Beverly Hills Ctr Special Surg, Ctr Hyperhidrosis, 1125 S Beverly Dr,Suite500, Los Angeles, CA 90035 USA Beverly Hills Ctr Special Surg 1125 S Beverly Dr,Suite 500 Los Angeles CA USA 90035
Citazione:
R. Reisfeld et al., "Endoscopic thoracic sympathectomy for treatment of essential hyperhidrosissyndrome: Experience with 650 patients", SURG LA E P, 10(1), 2000, pp. 5-10

Abstract

Patients with essential hyperhidrosis (EH) syndrome may experience subjective suffering and social/occupational challenges. We examined the safety and efficacy of minimally invasive endoscopic surgery for treating EH. Singlebilateral incisions, followed by endoscopic thoracic sympathectomy (ETS)-mediated bilateral ablation of the T2 sympathetic ganglia, were used to treat 650 patients with a primary diagnosis of palmar (90%) or facial hyperhidrosis (10%). Palmar and facial hyperhidrosis were resolved in 584 of 585 (>99%) and 62 of 65 (95%) patients, respectively. Surgery required less than 1hour, and no patient experienced a life-threatening adverse event. Compensatory sweating was observed in 83% of patients and was considered mild or moderate in approximately 67% of those patients. Innovations in ETS have resulted in minimally invasive, highly efficient, safe treatment of EH. Surgery is minimally intrusive to patients, who were usually discharged within 2 hours after surgery and able to resume normal activities within 1 week.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 15:52:56